Correlation Engine 2.0
Clear Search sequence regions


  • amino acid (1)
  • apoptosis (5)
  • ARF (3)
  • c Myc (15)
  • cdkn2a protein (1)
  • cell death (1)
  • Cyclin (2)
  • dependent (2)
  • Egr1 (3)
  • essential (1)
  • factor (1)
  • gene (1)
  • genes myc (2)
  • humans (1)
  • mice (1)
  • mutagenesis (1)
  • Myc protein (1)
  • p16 (2)
  • phase (2)
  • Skp2 (2)
  • target gene (1)
  • tumor suppressor protein (1)
  • ubiquitin (1)
  • Sizes of these terms reflect their relevance to your search.

    The oncogenic transcription factor c-Myc causes transformation and tumorigenesis, but it can also induce apoptotic cell death. Although tumor suppressors are necessary for c-Myc to induce apoptosis, the pathways and mechanisms are unclear. To further understand how c-Myc switches from an oncogenic protein to an apoptotic protein, we examined the mechanism of p53-independent c-Myc-induced apoptosis. We show that the tumor suppressor protein ARF mediates this switch by inhibiting ubiquitylation of the c-Myc transcriptional domain (TD). Whereas TD ubiquitylation is critical for c-Myc canonical transcriptional activity and transformation, inhibition of ubiquitylation leads to the induction of the noncanonical c-Myc target gene, Egr1, which is essential for efficient c-Myc-induced p53-independent apoptosis. ARF inhibits the interaction of c-Myc with the E3 ubiquitin ligase Skp2. Overexpression of Skp2, which occurs in many human tumors, inhibits the recruitment of ARF to the Egr1 promoter, leading to inhibition of c-Myc-induced apoptosis. Therapeutic strategies could be developed to activate this intrinsic apoptotic activity of c-Myc to inhibit tumorigenesis.

    Citation

    Qin Zhang, Erick Spears, David N Boone, Zhaoliang Li, Mark A Gregory, Stephen R Hann. Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity. Proceedings of the National Academy of Sciences of the United States of America. 2013 Jan 15;110(3):978-83

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 23277542

    View Full Text